Stimatix GI gets FDA approval for low-profile colostomy device

Israel-based Stimatix GI has FDA clearance for its AOS-C2000 colostomy product line that provides voluntary bowel evacuation and improves the quality of life for people with a stoma. A CE mark application for Europe is also under review and expected shortly. The filing activities in Europe are to be followed by post marketing surveillance, aiming at product readiness to market in the EU by the end of the year.

This article is tagged to:
Sector: Medical Devices
Geography: Israel

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.